Others

Torrent Pharmaceuticals Ltd. - Press Release - Glenmark & Torrent Sign Licensing Agreement For Co-Marketing Of Remogliflozin Etabonate In India

| Updated on July 11, 2019 Published on July 11, 2019

We would like to inform that the Company and Glenmark Pharmaceuticals Limited has signed licensing agreement for co-marketing of Remogliflozin Etabonate in India. A Press release, containing the transaction details, which is being submitted to the media is enclosed herewith for your information and record.

Pdf Link: Torrent Pharmaceuticals Ltd. - Press Release - Glenmark & Torrent Sign Licensing Agreement For Co-Marketing Of Remogliflozin Etabonate In India

Source : BSE - www.bseindia.com

Published on July 11, 2019
This article is closed for comments.
Please Email the Editor